Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: India Globalization Capital, Inc. IGC

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Enters MOU Related to Import and Distribution of Cannabinoid-Based Therapies in Germany

Posted on October 25, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has entered into a memorandum of understanding with MediCann Handels GmbH for the import and distribution … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Approaching Commercialization of IGC-AD1 in Early 2018

Posted on October 18, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model showing that, at … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s

Posted on October 13, 2017 by MissionIR

India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease (http://dtn.fm/tQo00). IGC is engineering genetic cell lines which … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital (NYSE: IGC) Announces Significant Breakthrough that Could Potentially Prevent, Fight Alzheimer’s Disease

Posted on October 11, 2017 by MissionIR

Seeks patent on new therapy for drug that employs concentrations of THC Data for drug candidate IGC-AD1 finds that it reduces buildup of ‘senior plaque’ without causing death of neurons, which can lead to memory loss IGC plans to commercialize … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on In Vitro Data Related to IGC-AD1

Posted on October 4, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital (NYSE: IGC) Demonstrates Potential in Alzheimer’s Treatment Market

Posted on October 3, 2017 by MissionIR

In response to compelling recent data, India Globalization Capital, Inc. (NYSE MKT: IGC) announced it has made a highly significant novel breakthrough in treating Alzheimer’s disease with tetrahydrocannabinol (THC)—an advancement that could potentially bring much-needed relief to Alzheimer’s sufferers. A … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) to Launch Medical Dispensary Product for Alzheimer’s Disease

Posted on October 2, 2017 by MissionIR

Product portfolio to include drugs and supplements Faster monetization of lead Alzheimer’s candidate as supplement Market valuation poised to soar It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Preparing to Bring Cannabis Combo Therapy for Alzheimer’s Disease to Trials

Posted on September 21, 2017 by MissionIR

Four drug candidates in the pipeline Potential sales of Alzheimer’s drugs run to billions Hyalolex heading for clinical trials India Globalization Capital, Inc. (NYSE MKT: IGC) is racing ahead with its preparation of medical trials for four drug candidates that … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Reports Promising Progress of Cannabis-Based Alzheimer’s Drug Candidate

Posted on September 18, 2017 by MissionIR

IGC is the only publicly traded cannabis stock with patent filings for treating Alzheimer’s disease Company has a first-mover advantage in phytocannabinoid-based combination therapy Alzheimer’s is America’s most expensive disease, costing the country an estimated $259 billion in 2017 It … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Provides Update on Data Showing Effectiveness of THC in Addressing Underlying Cause of Alzheimer’s

Posted on September 18, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning provided an update on compelling in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model. … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment